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1. Introduction 
A carbodiimide-binding proteolipid subunit has 
been identified in the energy-transducing ATPase 
complex from eukaryotic and prokaryotic cells 
[1-4]. lncreasing evidence is being accumulated that 
the proteolipid (Mr 8000) in oligomeric, most likely 
hexameric, form [2] constitutes the proton-conductor 
of the ATPase membrane factor, F 0 [5-7]. The amino 
acid sequence has been determined for the A TPase 
proteolipid ~rom various mitochondria (Neurospora 
crassa. Saccharomyces cerevisiae, bovine heart), 
chloroplasts (spinach) and bacteria (Escherichia coli, 
PS-3) [8]. Dicyclohexylcarbodiimide (DCCD), an 
effective inhibitor of the proton-translocating activity 
of the ATPase complex [ 4,9, 1 0], binds selectively to 
one acidic amino acid side chain (glutamic or aspartic 
acid) [8,11 ]. 
From E. coli numerous ATPase mutants of the uncB 
phenotype have been isolated [12]. These mutants 
contain a functional F 1 ATPase, but the membrane 
factor, F0 , is defective [12,13]. In contrast to the 
E. coli wild-type, removal of the F 1 ATPase from the 
mutant membrane does not result in a proton leak. 
We are presently engaged in screening several of these 
uncB-type mutants for alterations in the amino acid 
sequence of the ATPase proteolipid. An analysis of 
structural gene mutants hopefully allows an identifi-
cation of those amino acid residues of the proteolipid, 
which areessential for the function and/or assembly 
of the proton-translocator. Furthermore, a structural 
gene mutant will be useful for the cloning and isola-
tion of the proteolipid gene. As a first result of these 
protein-chemical studies, this communication de-
scribes an uncB-type mutant with a single amino acid 
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exchange in the A TPase proteolipid. The purified 
CNBr fragments of the mutant and wild-type proteo-
lipid were studied by thin-layer chromatography and 
amino acid analysis. The exchange could be localized 
in one fragment, whose amino acid sequence was 
determined. Interestingly enough, the carbodiimide-
reactive aspartyl residue in position 61 of the poly-
peptide chain [ 11] was found to be substituted by a 
glycine in the mutant proteolipid. 
2. Materials and methods 
E. co/i Kl2 Ymel (A.), p- (lacl, fadR, but12, 
rha, ilv, metE), and its derivative the uncB-type 
mutant DG 7/1 were grown in CR medium with 1% 
glucose as carbon source, supplemented with isoleu-
cine, valine and methionine, each at 0.1 l)lg/ml [13]. 
Cells (0.8-1.0 kg wet wt) were obtained from 200 1 
cultures grown to late log phase. The cells were 
incubated with Iysozyme {1 mg/g wet wt) and DNase 
(20 JJ..g/g wet wt) for 3 hat room temperature. Then 
a crude membrane fraction was sedimented at 
8000 X g for 15 min. The ATPase proteolipid was iso-
lated by extraction of whole membranes with chloro-
form/methanol 2:1 [3] and subsequent carboxymeth-
yl-cellulose chromatography [ 14]. The pure E. coli 
proteolipid was eluted from the column during the 
wash with chloroform/methanol/water (5:5: 1} (14]. 
The proteolipid ( 4 mg Lowry protein) was cleaved 
at its 8 methionyl residues [8,11] by incubation in 
1 ml1 M CNBr in 80% formic acid at room tem-
perature for 18 h. The resulting fragments were 
submitted to chromatography on Bio-Gel P-30 
{ -400 mesh) in the presence of 80% formic acid. 
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Chromatographie fractions containing cyanogenbro-
mide fragments (I) B-6, (II) B-7 and B-8, (III) B-4 
and (IV) B-2, B-3 and B-9 were combined and dried 
over KOH in vacuo. The pooled fractions were dis-
solved in trifluoroacetic acid and dried over KOH in 
vacuo, 2 times, in order to convert C-terminal homo-
serine into the lactone. Then the individual peptides 
were further separated and purified by preparative 
thin-layer chromatography (DC Fertigplatten, 
0.25 mm Kieselgel 60, mit Konzentrierungszone; 
Merck, Darmstadt) using n-butanol/acetic acid/pyri-
dine/water (68: 14:40: 25) as solvent. The developed 
plates were superficially spraycd with 0.025% 
fluorescamine in acetone. Peptides were eluted from 
the silica gel with 98% formic acid. Analytical plates 
(HPTLC Fertigplatten, Kieselgel 60, mit Konzen-
trierungszone; Merck, Darmstadt) were developed 
with the same solvent as the preparative plates. 
For determination of the amino acid composition, 
the whole proteolipid and CNBr fragments were 
hydrolysed in 6 N HCI for 24 h and 72 h at 1 05°C. 
Methionine was determined as its sulfone aftcr per-
formic acid oxidation [ 15]. The samples were 
analysed on a LC 2000 (Biotronik, München) amino 
acid analyzer. N-terminal amino acids were identified 
by the dansylation method [16]. 
Aminoacid sequences were determined by auto-
mated solid-phase Edman degradation with the 
Sequemat, model 12, sequencer (Sequemat, Water-
town, USA) using the standardprogram with minor 
modifications [17]. The whole protein (1.5 mg Lowry 
protein) dissolved in chloroform/methanol 2: 1 was 
coupled to 3-aminopropyl glass [18] via carboxyl 
group(s) by the carbodiimide coupling procedure 
[19J. CNBr fragments B-7 were coupled to the ami-
nated glass using the homoserine lactone coupling 
procedure [ 19]. The cleaved-off thioazolinone amino 
acids were converted into the phenylthiohydantoine 
derivatives by a 15 min incubation at 65°C with 
acetylchloride/methanol (2:8) [20], and then identi-
fied by thin-layer chromatography [21]. 
3. Results 
MutantDG 7/1 was selected after mutagenesis with 
N-methyl-N' -nitro-N-nitrosoguanidine by the proce-
dures in [22]. The mutation maps between asn and 
ilv in the uncA,B region of the E. coli chromosome 
[12). The mutant contains a functional F 1 ATPase, 
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which, however, is not inhibited by DCCD. A 
functional membrane integrated part of the ATPase 
complex is lacking [13]. According to this phenotype, 
strain DG 7/1 is classified as an uncB-type mutant. 
The amino acid sequence of the ATPase proteolipid 
from E. coli wild-type K 12 has been published in 
preliminary form [8,11 }. During the present studies 
this sequence could be confirmed with the exception 
that at position 37 repeatedly a glutamic acid was 
identified instead of a glutamine. This proteolipid 
consists of 79 amino acid residues. It contains 8 
methionines, including aN-terminal formylmethionine 
and a methionine-methionine sequence at position 
16/17. Thus, besides formyh'lomoserine and homo-
serine, 7 fragments are produced by CNBr cleavage. 
Analysis by thin-layer chromatography reveals that 
the corresponding fragments from the proteolipid of 
the wild-type and mutant DG 7/1 exhibit the same 
RF value with the exception of fragment B-7 (fig.l). 
The mutant fragment migrates considerably faster. 
Amino acid analysis of the CNBr fragmcnt B-7 from 
mutant DG 7/1 shows an aspartic acid residue less 
and an extra glycine residue in comparison with the 
corresponding wild-type fragment (table 1). No signif-
icant differences could be detected when the amino 
acid compositions as well as the N-terminal residues 
of the other fragments were compared (data not 
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Fig.l. Thin-layer chromatography of CNBr fragments of the 
ATPase proteolipid of the wild type and uncB-type mutant 
DG 7/1 from E. coli. The fragments from wild type (W) and 
mutant (M) are numbered according to their occurrence in 
the amino acid sequence [ 11 ). Fragments B-1 (formylhomo-
serine) and B-5 (homoserine) arenot included. 
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Table 1 
Aminoacid composition of the proteolipid and CNBr fragment B-7 from the wild-type and 
uncB mutant DG 7/1 of Escherichia coli 
Residue Proteelipid (mol/mal) CNBr fragment B-7 (mol/mal) 
Wild-type Mutant DG 7/1 Wild-type Mutant DG 7/1 
Aspartic acid 5.15 
Methionine sulfone 7.7 
Threonine 1.18 
Homoserine 
Glutamic acid 4.13 
Praline 2.78 
Glycine 9.6 
Alanine 12.8 
Valine 5.4 
Isoleueine 6.8 
Leueine 11.8 
Tyrosine 1.69 
Phenylalanine 3.76 
Lysine 1.14 
Arginine 2.16 
(5) 4.15 
(8) 7.4 
(l) 0.95 
(4) 3.96 
(3) 2.86 
(10) 10.6 
(13) 12.8 
(6) 5.5 
(8) 6.95 
(12) 11.6 
(2) 1.88 
(4) 3.8 
(1) 1.27 
(2) 1.91 
1.08 (1) 
0.58 (1) 
0.9 (1) 
!:Q_ (1) 
1.07 (1) 
0.91 (1) 
0.93 (l) 
0.98 (1) 
0.48 (1) 
0.9 (1) 
2.01 (2) 
1.17(1) 
0.88 (1) 
0.99 (1) 
1.08 (1) 
The proteolipid contains no serine, histidine and tryptophan [ 4,11 ]. The numbers in parenthesis 
were determined by sequence analysis [ 11 ]. 
shown). The N-terminal formylmethionine and the 
methionine-methionine sequence (positions 16/17), 
which remained undetermined during the analysis of 
the cyanogenbromide fragments, were identified by 
sequencing the whole mutant protein up to 
position 43. When the amino acid composition of the 
whole mutant proteinwas analysed (table 1 ), the only 
significant differences occurred in the number of 
aspartic and glycine residues. Accordingly, the aspartic 
acid/glycine exchange most likely is the only alteration 
of the proteolipid produced by the mutation in strain 
DG 7/1. 
Aminoacid sequence analysis of CNBr fragment 
B-7 from wild-type and mutant DG 7/1 revealed 
( fig.2) that at one position ( cycle 4) an aspartic acid 
is substituted by a glycine. The amino acid exchange 
occurs at position 61 of the E. coli proteolipid. 
4. Discussion 
The present sturlies established an amino acid 
exchange in the amino acid sequence of ATPase 
proteolipid from the uncB-type mutant DG 7/1 of 
E. coli. Remarkably, the aspartyl residues substi-
tuted by a glycine in the mutant proteolipid occurs 
at the same position which previously has been shown 
to correspond to the carbodiimide-reactive residue 
[11 ]. This finding is in accordance with the obser-
vation that the mutant proteolipid can not be modified 
by [14 C] dicyclohexylcarbodiimide (unpublished 
results). Recently, the amino acid composition of 
another uncB-type mutant (GD 7/1 0) has been report-
ed, which no Ionger binds the carbodiimide [23]. 
Since an extra glycine and a missing aspartic acid 
was determined as the only alteration, it is a distinct 
possibility that this strain contains the same mutation 
as strain DG 7/1. It has tobe mentioned, however, 
that we have analysed several uncB-type mutants, 
which do not bind carbodiimide, and which exhibit 
no alteration in the ATPase proteolipid, when the 
amino acid compositions of CNBr fragments are ana-
lysed. 
At the moment, the primary lesion produced by 
the aspartic acid/glycine exchange in mutant DG 7/1 
remains undetermined. Preliminary evidence suggests, 
that the mutant proteolipid is still assembled with the 
F 1 A TPase, since the whole A TPase complex, F 1 F 0 , 
can be precipitated with antiborlies raised against the 
F 1 protein (P. Friedl, unpublished results). This sug-
gests that the amino acid exchange in the mutant 
results in a non-functional proton-translocator, rather 
than in a non-assembled membrane factor. This would 
indicate that an acidic group at position 61 of the 
109 
Valurne 109, number 1 FEBS LEITERS January 1980 
WILDTYPE 87 MUTANT DG 7/1 B 7 
s II 111 II I II 111 11 
CYCLE 1 2 3 4 5 6 7 8 1 2 3 4 5 6 7 8 
Fig.2. Aminoacid sequence of CNBr fragment B-7 of the proteolipid from wild-type and uncB-type mutant DG 7/I. The amino 
acid derivatives released during cycle 1-8 of a~tomated solid-phase Edman degradation were id~ntified by thin-layer chromatog· 
raphy using chloroform/ethanol 98/2 as the developing solvent. The calibration standards (S) of the phenylthiohydantoine amino 
acids contained (I) leueine (L), methionine, Iysine, threonine, glutamine, arginine, (II) proline (P), valine (V), alanine (A), glycine 
(G), serine, asparagine and (III) isoleueine (1), phenylalanine, aspartic acid methylester (D), glutamic acid methylester, tyrosine, 
glutamic acid, aspartic acid. HS designates the derivative of homoserine. 
proteolipid is essential for the proton-conducting 
activity of the ATPase membrane factor. The impor-
tance of this acidic residue has been inferred already 
from the observation, that this is the only acidic 
residue which has been conserved during evolution [8]. 
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